FDANews
FDAnews Device Daily Bulletin

Report: J&J’s Synthes Purchase Pushed Devices to Top of M&A Heap in 2012

April 9, 2013
Johnson & Johnson’s purchase of Synthes helped to make medical devices the most profitable life sciences sector in terms of mergers and acquisitions (M&A) in 2012, a recent PricewaterhouseCoopers (PwC) analysis shows. Overall, life sciences M&A value dropped by 19 percent, fueled in part by caution leading up to the November elections and the “fiscal cliff” negotiations, the report says. Overseas investment was dampened by the Eurozone debt crisis, weak labor markets and slow growth in emerging markets.
Devices & Diagnostics Letter